Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Dopamine
Therapeutic Area : Neurology
Study Phase : Phase I/ Phase II
Recipient : University Hospital, Lille
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Dopamine is a Hormone drug candidate, which is currently being evaluated in Phase I/ Phase II clinical studies for the treatment of Parkinson Disease.
Product Name : Undisclosed
Product Type : Hormone
Upfront Cash : Inapplicable
October 09, 2025
Lead Product(s) : Dopamine
Therapeutic Area : Neurology
Highest Development Status : Phase I/ Phase II
Recipient : University Hospital, Lille
Deal Size : Inapplicable
Deal Type : Inapplicable